Lin Ping

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacology +17

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin

Matthew C. Riddle, Ronnie Aronson, Philip Home et al. · Diabetes Care · 2013 · 285 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine

Matthew C. Riddle, Thomas Först, Ronnie Aronson et al. · Diabetes Care · 2013 · 251 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley–Lewis, David Aguilar, Matthew C. Riddle et al. · American Heart Journal · 2015 · 99 citations · Full text

Medicine, Cardiology, Pharmacology +14

A randomized trial comparing the rate of hypoglycemia-assessed using continuous glucose monitoring-in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study)

Thomas Danne, Areti Philotheou, David Goldman et al. · Pediatric Diabetes · 2013 · 49 citations · Full text

Medicine, Endocrinology, Pediatrics +17